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Background: EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that
has received attention is the selection of the states for direct valuation by respondents. Changes in the valuation
subset have been found to change the coefficients of the utility function. The purpose of this study was to test the
performance of valuation subsets based on orthogonal experiment designs. The design of the study also allowed a
comparison of models based on raw or untransformed VAS values with values transformed at the level of the
respondent and at the aggregate level.
Methods: Two different valuation subsets were developed based on orthogonal arrays. A VAS elicitation was
undertaken with two groups of similar respondents and the resulting utility functions based on the valuations of
the two different valuation subsets were compared using mean absolute errors between model and observed
values, and by correlation with values in and out of sample. The impact of using untransformed versus VAS values
transformed at the level of the individual and at aggregate level and the inclusion of a constant term in the utility
functions were also investigated.
Results: The utility functions obtained from the two valuation subsets were very similar. The models that included
a constant and based on raw VAS values from the two valuation studies returned rank correlation coefficients of
0.994 and 0.995 when compared with respective observed values. MAEs of model values with observed values were
2.4% or lower for all models that included a constant term. Several models were developed and evaluated for the
combined data (from both valuation subsets). The model that included the N3 term performed best.
Conclusions: The finding that two very different valuation subsets can produce strikingly similar utility functions
suggests that orthogonal designs should be given some attention in further studies. The impact of rescaling VAS
values at the level of the individual versus at aggregate level had minimal impact on the performance of the
models when compared to models based on the raw VAS values.
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Health states defined by EQ-5D and other health status
classification systems such as HUI [1] and SF-6D [2] are
typically represented by a summary index score computed
once the value of different dimensions and levels within
dimensions have been established. Studies that generate
such value sets for these instruments often adopt a similar
approach in order to overcome the respondent burden in-
volved in assessing large numbers of health states. In the
case of EQ-5D-3L a total of 243 health states are defined
by the descriptive classification, there being 5 dimensions
(mobility, self care, usual activities, pain/discomfort and
anxiety/depression) for each of which there are 3 possible
responses levels. The response level for each dimension is
used to create a numeric code that acts as a nominal de-
scriptor for each state. The logically best health state is
coded as 11111 (no problem on any of the 5 dimensions);
the logically worst health state is coded as 33333 (an ex-
treme problem on all 5 dimensions). It is usually the case
that a smaller number of selected health states are pre-
sented for direct evaluation in any valuation study. These
directly observed values are then used to construct a
statistical model from which to estimate the value decre-
ments associated with each dimension/level. These de-
rived values are then applied to compute index scores for
the full set of health states defined by the classification
system.
Valuation studies have taken several approaches when
selecting a subset of EQ-5D states for direct assessment.
The first large EQ-5D valuation study was the Measure-
ment and Valuation of Health (MVH) study in the United
Kingdom carried out in 1993 [3].
The MVH protocol used a subset of 43/243 EQ-5D
states plus unconscious and immediate death (a total of
45 states). Valuation of all states in this subset was con-
sidered to be too much by way of respondent burden
and a block design was used so that each respondent
evaluated a total of 15 states. The reduction of respond-
ent burden in this way necessitated an increase in the
size of the study sample. Subsequent interest in identify-
ing efficient subsets for EQ-5D valuation studies has
yielded a number of alternative designs.
The valuation subset used in the MVH study com-
prised 43 states that were selected to cover a wide range
of severity, to maintain consistency with an earlier study
that had been conducted in Finland, and to include only
states that would be considered by the researchers to be
‘plausible’ to the average respondent [4]. As an example
of the ‘plausibility’ criterion, any states that combined
level 3 on Mobility (confined to bed) with level 1 on
ability to perform Usual Activities or Self Care (that is
all states comprising 3X1XX or 31XXX) were excluded.
One study [5] that specifically set about to investigate
the performance of valuation sets for EQ-5D evaluatedseveral subsets of states used in the MVH study by test-
ing the performance of models in terms of correlation
between observed and predicted values and Mean Abso-
lute Error (MAE). This study used a backward sequential
elimination algorithm to remove the state at each step
with the smallest effect on the regression models. A final
subset of 17 states referred to as the Macran and Kind
States performed best on the correlation criteria. These
analyses were conducted on the MVH data.
In another study that was based on MVH data, Lamers
et al. [6] used simulated sampling strategies to model
the performance of various subsets of the MVH valu-
ation set. The resulting models were compared in terms
of correlation and MAE with observed values. This ap-
proach was not able to identify a valuation subset that
outperformed the Macran and Kind Set.
Zarate and Kind [7] attempted to identify smaller valu-
ation subsets in other countries that had conducted EQ-
5D-3L valuation studies using the MVH valuation set.
This approach was taken for data from the USA, Chile
and the UK. In all three cases, the minimum number of
states in the valuation subset that could be kept while
avoiding a ‘large’ increase in MAE versus observed values
was 17. Removal of further states from the valuation set
resulted in MAE of the model values versus observed
values moving from 0.05 to over 0.1 (on a 0–1 scale) in all
three cases. The problem was that the identity of the 17
states differed between the three countries in the study.
This suggests that a single small (eg 17 state) valuation
subset that can be applied to all countries may not exist
however a common set of 31 states was found which may
perform reasonably well when applied to the data for the
three countries in the study. These studies suggest that
the states comprising the valuation subset affect the model
that is obtained.
Other EQ-5D valuation studies have used the Macran
and Kind subset combined with 8 other states drawn
randomly from the rest of the MVH set [8,9].
A large valuation subset comprising 101 states was used
in South Korea [10]. Using large valuation subsets may
improve precision since this leaves fewer states that must
be valued based on modeling. However, using large valu-
ation subsets also increases the number of respondents re-
quired in valuation studies, since blocking methods must
be used to break the subset into smaller components for
valuation by individual respondents.
Bagust [11] attempted to build a valuation subset using
a set of four explicit quantifiable criteria:
1. Plausibility: by examining large empirical data sets to
find states that are observed in the population for
which the value set is being developed.
2. Relevance: the states selected for direct valuation
should be those most frequently reported by the
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3. Coverage over severity range: This is related to the ‘code
score’ of an EQ-5D state which is obtained by adding
the value of the level of each dimension in the state.
Thus state 11111 has a code score of 5 × 1 = 5, and state
12223 would have a code score of 1 + (3 × 2) + 3 = 10.
The state that lies furthest from 11111 is 33333 which
has a code score of 5 × 3 = 15. This measure gives a
general indication of severity, so a valuation set based
on this approach would include states covering all
possible levels of code score from 5 to 15.
4. Simple severity increments: valuation subsets should
comprise states that represent single ‘adjacent steps’
(i.e. states having a difference in code score of 1) in
progressing from 11111 to 33333. It is argued that
this would allow direct measurement of the lowest
level of differentiation that can be obtained from the
EQ-5D-3L system.
This approach produces a set of 55 states in 5 blocks,
so that each respondent values a sub-set of 11 states.
The study developed a valuation subset based on MVH
data, but there is no application or empirical data re-
garding the performance of this valuation set. The ap-
proach would require the self reported EQ-5D states for
thousands of citizens of the country for which a value
set is being developed in order to identify the states that
meet criteria 1 and 2. Most developed countries now
have EQ-5D Value Sets [12]. Moving forward, it is
expected that ‘new’ countries for which EQ-5D-3L value
sets are to be developed will comprise middle income or
developing countries for which self reported health for
such large numbers of citizens will not be available. This
approach also requires 5 respondents per replicate.
The purpose of our study was to test the performance of
valuation subsets based on orthogonal experiment designs.
An orthogonal design is one in which the columns of the
independent variables are orthogonal to each other. For
the design of an EQ-5D valuation subset, this would mean
that in each replicate, each level of every dimension would
appear an equal number of times. Historically, orthogonal
experiment designs have been used extensively in many
fields [13]. For this study, a Visual Analogue Scale (VAS)
was used to capture the observed values.
The design of this study also allowed the opportunity to
test two further issues involved in modeling EQ-5D valu-
ation data. These are 1- the question of whether to trans-
form the VAS values (on to a 0 to 1 scale) at the level of
the individual, or at the aggregate level, and 2- the effect
of the inclusion of a constant term and additional dummy
variables in the regression model.
In order to derive weights that would enable EQ-5D
states to be used as quality-adjustment scalars in QALYcalculations, the data must be rescaled using a mono-
tonic transformation to map the Visual Analogue Scale
(VAS) values of states on a 0 to 1 scale, corresponding
to the states dead and full health respectively. One ap-
proach is to carry this transformation out at the level of
the individual respondent using an adjustment:
VASRescaled ¼ VASRaw–DeadRaw½   11111Raw–DeadRaw½ 
The same form of transformation could be applied to
aggregated observed data taking the mean value, for ex-
ample, as the measure of central tendency. The advan-
tage of this approach is that it effectively dampens the
effect of variability within an individual respondent’s
data thereby introducing a degree of smoothing and po-
tentially giving rise to a simplified estimation model. On
the other hand, this approach could be criticized for los-
ing some of the individual data. To compare these two
approaches, regression analyses were run on VAS values
transformed at the level of the individual and at aggre-
gate level. The regression analyses were also run on the
raw or untransformed VAS values to allow for compari-
son with the models based on transformed VAS values.
A further element of consideration in developing esti-
mation models was the use of a constant term. Many EQ-
5D valuation studies include a constant term which is
interpreted behaviorally as representing the value decre-
ment accounted for by any departure from full health [14].
However, the impact of including such a constant term
has not been the subject of any systematic investigation.
Its inclusion seems to be a consequence of adopting previ-
ous custom and practice rather than being a deliberate
choice. The use of a constant term may mask imperfec-
tions in the specification of the model and/or the volume
of information under investigation and its use may simply
be to act as a proxy for unobserved variance not otherwise
specified. Alternate models were developed in this study
in which the regression lines were forced through the ori-
gin. These models were considered and evaluated as coun-
terfactuals to the models in which the constant term was
permitted.
Methods
Two valuation subsets were designed, the first of which
(labeled ‘Green Set’) was created using a pre-existing or-
thogonal array [15] and is shown in Figure 1. The sec-
ond (labeled ‘Blue Set’) was derived from the first by
adding generator 11111 to each member of the first or-
thogonal array using modulo 3 arithmetic. EQ-5D states
11111, 33333 and ‘Dead’ were added to each set as an-
chors, along with two further ‘hold-out’ states which
were not included in the regression analysis but were
used to evaluate models produced by the analysis. The
total number of states valued by each responded was 23,
Figure 1 Valuation subsets.
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rays plus these 5 additional states (11111, 33333, ‘Dead’
and the two holdout states).
A sample of 230 university students took part in a
valuation exercise conducted at the St. Augustine
campus of the University of the West Indies. All of the
elicitations were conducted in a 1:1 office setting and
respondents received TT$50.00 (equivalent to US$8) at
the start of the interview. Respondents were randomly
assigned to the Green and Blue valuation sets.
Respondents were first asked to complete the standard
EQ-5D self-classifier that records their own assessment of
their health status and was designed as a ‘warm up’ task to
build familiarity with the descriptive system in original
EQ-5D valuation studies. Upon completion respondents
were handed a set of cards containing descriptions of EQ-
5D health states. The cards were 4 cm × 12 cm in size
with protruding rhomboid edges that made them hex-
agonal as is shown in Figure 2. Each respondent was ran-
domly assigned to one of two ‘Green’ and ‘Blue’ sets.
Each card had a two letter code printed in the bottom
right corner so that the interviewer could record the
rank data and VAS valuations. It was explained to the re-
spondents that these codes were generated randomly
and had no significance.
The cards were ranked from best to worst along the
edge of a desk with respondents first being handed two
randomly selected cards and instructed to place one card
on the desk and decide whether the second was better or
worse than the first, placing it above or below accordingly.
A third card was then introduced and the respondent was
asked to decide whether this should go above, below or inFigure 2 Example of an EQ-5D-3L Ranking/VAS card.between the other two. This process was repeated until all
23 cards for that respondent were ranked. Tied ranks were
permitted.
Once this ranking task was complete the interviewer
noted the order of health states and then placed a 1-metre
version of the VAS alongside the ranked cards. Respon-
dents adjusted the location of each card so that the rhom-
boid edge pointed to the VAS rating corresponding to
their assessment of the value of each state on the 0 – 100
scale. This allowed the respondent to see all of the cards
on the VAS at the same time and to adjust their positions
and values. Respondents were reminded that ties were per-
mitted and that they had the freedom to change the order
of states if they so chose. Interviewers had been instructed
that if a respondent raised the issue of an implausible state,
they were to respond with a statement explaining that
some people do find that some of the states are difficult to
imagine and to encourage respondents to carry out the
valuation (or ranking task) for the state to the best of their
ability. Once the VAS task was finished the interviewer re-
corded the rating scores for all health states.
The use of orthogonal subsets can present special chal-
lenges to the respondent when compared to subsets de-
signed in other ways, such as those used in the MVH
study. The MVH study sought to avoid implausible states,
however these are an inevitable feature when using an or-
thogonal array that brings every level of every dimension
together with every level of every other dimension. Here
implausible states cannot be avoided—for example states
combining ‘confined to bed’ with ‘no problems’ on the ‘Self
Care’ and ‘Usual Activities’ dimensions were observed in
both the Green and Blue valuation subsets. Further, the
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progressively more “severe” categories (mild, moderate
and severe states). The orthogonal sets are more concen-
trated with more than half of the states in the moderate
code score range of 8–11, so that preferences among the
states are less obvious to respondents using the orthogonal
sets (Figure 3). Generally, respondents would be expected
to have greater difficulty in assigning ranks and values
among sets of states that are more similar in severity/code
score than among sets in which states that are further
apart in terms of severity [16].Analysis
Although panel regression methods would generally be
appropriate, the analysis of pooled data from an orthog-
onal experiment design using ordinary least squares
(OLS) regression produces identical coefficients to fixed
and random effects models [17]. Given that the valu-
ation sets used in this study were based on orthogonal
arrays, the models were produced using OLS. All regres-
sion analyses were carried out using Stata Statistical
Software 12.0.
In the absence of having access to a ‘true’ underlying
utility function, the models obtained in EQ-5D valuation
studies are usually evaluated on such criteria as internal
validity, Mean Absolute Error (MAE) versus observed
values, R-Squared etc. In addition to these criteria, this
study design allowed for a comparison between the util-
ity functions based on valuations by two groups of simi-
lar respondents, using two completely different valuation
subsets (with no states in common) that were both de-
veloped from orthogonal arrays.
Statistical analysis was conducted in two stages. In the
first stage, 6 different model specifications were used toFigure 3 A Comparison of the orthogonal valuation sets with a typicaanalyse the two respondent data sets (Blue and Green)
as follows:
Model 1: with the dependent variable as 100 – raw
VAS value with no constant term in the model.
Model 2: with the dependent variable as the raw VAS
value with a constant term in the model.
Model 3: with the dependent variable as 1 –VAS value
rescaled at the level of the individual respondent with
no constant term in the model.
Model 4: with the dependent variable as the VAS value
rescaled at the level of the individual respondent with a
constant term in the model.
Model 5: with the dependent variable as 1 –VAS value
rescaled at aggregate level using mean values with no
constant term in the model.
Model 6: with the dependent variable as the VAS value
rescaled at aggregate level using mean values with a
constant term in the model.
Testing models 3 through 6 allowed a comparison of
the performance of models with and without the con-
stant term, as well as with VAS values transformed at
the level of the respondent and at aggregate level. In-
cluding models 1 and 2 allowed a comparison of the
models with equivalent analyses based on untransformed
VAS values. Each model was evaluated using the follow-
ing criteria - adjusted R2, within-sample correlation, cor-
relation with out-of-sample values, MAE of estimated
and observed values, and the percentage of model versus
observed residuals that were above 5% (i.e. residuals
above 5 VAS points for the Raw VAS models and resid-
uals above 0.05 for the Rescaled models).
In the second stage of the analysis, the best performing
model using rescaled data based on these criteria wasl MVH set by code scores.
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the Blue and Green observed values). The performance
of this model was compared with variants of this base-
line model that included dummy variables which had
previously been specified in the other valuation studies.
These dummy variables indicated the presence of any
1’s, 2’s and 3’s in a state (N1, N2 and N3 respectively). In
addition to these, regressions were also run with dummy
variables giving the numbers of 1’s, 2’s and 3’s in a state
(C1, C2 and C3 respectively) and the squares of these
counts (C1Sq, C2Sq, C3Sq). These regressions were run
to test whether these additional variables would improve
performance over the baseline model.
These models were compared based on adjusted R2,
correlation of model values with observed values, and
MAE of model values and values observed for the sam-
ple and hold out states.
Results
230 individuals participated in this study. The median
age was 20 and 40% were male. The rates of self-
reported problems as shown in Table 1 vary across the
EQ-5D dimensions with only 1 respondent recording
any problem with self-care compared to 90 respondents
(=39%) who reported a problem with anxiety/depression.
The self-reported health status as indicated by the mean
of their VAS ratings was 76.1 (s.d. =13.5).
Valuation data for the two sets of 23 states were ob-
tained from 112 (Blue) and 117 (Green) respondents re-
spectively. VAS values were obtained for 38 EQ-5D
states plus dead. The mean observed values and corre-
sponding transformed scale values are given in Table 2.
Results of the first stage are presented in Table 3. The
models based on VAS values transformed at the aggre-
gate level and excluding the constant term had higher
adjusted R2 values than the other models. However on
the criteria that deal with predictive ability (MAE and
correlation measures) the models that included the con-
stant term outperformed those that exclude it for both
the green and the blue set. Comparing the models based
on the VAS values transformed at the two levels that in-
clude the constant term, Model 6 has a higher adjusted
R2, but Model 4 has better MAE and correlation mea-
sures. These differences are very small.Table 1 Problem rates reported by the respondentsa
% of Respondents
Level 2 Level 3
Mobility 2.6% 0.4%
Self-care 0.4% 0.0%
Usual activities 12.2% 0.0%
Pain/Discomfort 36.5% 0.9%
Anxiety/Depression 33.5% 5.7%Figures 4 and 5 show the performance of the model
based VAS values from the Green data set (Model 2)
compared to the observed values from the Green and
Blue sets.
The models based on the green and blue data sets com-
prise very similar coefficients. This similarity is displayed
in Figure 6 where the coefficients for the models based on
raw VAS values from the two data sets (Model 2) are com-
pared. This pattern of very similar coefficients also follows
for models based on data transformed at both levels.
The effect of including additional dummy variables was
investigated using Model 4 for the combined data set
(green plus blue). Table 4 shows the value decrements for
each dimension/level using a baseline regression model
that utilises VAS values transformed at the level of the in-
dividual and including a constant term. Only models that
were internally valid are displayed (the C1, C2, C3, C1Sq
and C2Sq models all included counterintuitive coefficients
with level 2 having a higher absolute decrement than level
3 for one or more dimensions). The N3 model outper-
formed the other 4 models in Table 4 on all five criteria
that were used for this comparison (R2 as well as the pre-
dictive measures). The magnitude of these improvements
in performance is however small.
Discussion
The challenges associated with the orthogonal design (in-
clusion of implausible states and the concentration of
states in the moderate range) would have contributed to
the relatively low Spearman’s rank correlation coefficients
between the results of the ranking task and the ranks of
VAS scores of 0.8880 and 0.8884 for the orthogonal valu-
ation subsets (versus 0.94-0.96 for most of the studies that
use the MVH protocol). Only 4 respondents in our study
(1.7%) preserved the rank order of the states in moving
from the ranking task to the VAS task (versus 19% in the
MVH study). If it is accepted that the ranking task pro-
duces the ordinal preferences of the respondent, then the
transfer of cards to the VAS allows the respondent an op-
portunity to correct any mistakes made during the initial
ranking task. Such errors would be most likely among
states perceived to be very similar in terms of preference
level to the respondent [16]. This is an exploratory study.
It was not designed to produce a value set that can be used
in resource allocation decision making, but to test the per-
formance of orthogonal valuation subsets and to investi-
gate the impact of modeling and transformation strategies
on the utility function. Thus, the respondents used were
students because this allowed the convenient creation of
two similar respondent groups. Their demographic char-
acteristics and problem rates in Table 1 would not reflect
the general population of Trinidad and Tobago. The
sample size was also small relative to the sample sizes of
VAS studies in the published VAS valuation studies [14].
Table 2 Mean observed and rescaled VAS valuesb
State Set Observations VAS untramsformed VAS rescaled individual VAS rescaled aggregate
Mean St. dev Mean St. dev Mean St. dev
11111 Both 229 97.5 6.3 1.0000 0.0000 0.9828 0.0474
11123 Green 112 73.1 21.3 0.7404 0.2584 0.7461 0.2221
12122 Green 112 68.0 20.7 0.6828 0.2359 0.6928 0.2157
11313 Green 112 66.6 19.1 0.6794 0.2301 0.6781 0.1990
13111 Blue 117 66.5 20.3 0.6716 0.2086 0.6774 0.2115
21212 Green 112 64.3 19.3 0.6506 0.2314 0.6540 0.2010
21122 Blue 117 63.8 16.5 0.6494 0.1707 0.6486 0.1715
11223 Blue 117 61.4 22.5 0.6255 0.2317 0.6242 0.2343
12113 Blue 117 58.9 21.7 0.6012 0.2236 0.5981 0.2264
22121 Blue 117 58.7 18.3 0.5979 0.1858 0.5954 0.1901
13311 Green 112 57.5 23.3 0.5799 0.2390 0.5834 0.2421
11331 Blue 117 57.1 19.0 0.5784 0.1975 0.5786 0.1979
21131 Green 112 56.4 19.8 0.5678 0.2181 0.5716 0.2058
21312 Blue 117 56.0 18.2 0.5651 0.1877 0.5679 0.1891
12232 Green 112 52.8 22.1 0.5284 0.2434 0.5340 0.2302
13222 Blue 117 51.1 20.1 0.5179 0.2072 0.5163 0.2089
22213 Green 112 49.3 17.4 0.4947 0.2090 0.4983 0.1820
22321 Green 112 48.9 17.8 0.4898 0.2029 0.4939 0.1853
13231 Green 112 48.1 23.6 0.4771 0.2446 0.4857 0.2457
12332 Blue 117 46.6 19.3 0.4707 0.2017 0.4696 0.2008
22231 Blue 117 43.9 18.1 0.4431 0.1859 0.4415 0.1888
23322 Green 112 40.0 19.0 0.3940 0.2152 0.4010 0.1978
31211 Blue 117 37.1 22.1 0.3717 0.2335 0.3709 0.2305
23313 Blue 117 36.8 18.9 0.3686 0.2077 0.3678 0.1970
32111 Green 112 33.1 20.5 0.3214 0.2406 0.3297 0.2134
23133 Green 112 31.0 18.8 0.2969 0.2198 0.3069 0.1960
32212 Blue 117 29.8 19.0 0.2960 0.2022 0.2953 0.1974
31221 Green 112 29.7 18.8 0.2864 0.2291 0.2939 0.1956
23233 Blue 117 28.1 17.7 0.2801 0.1841 0.2774 0.1846
33112 Green 112 23.9 16.8 0.2254 0.2141 0.2337 0.1747
31133 Blue 117 22.6 16.5 0.2193 0.1779 0.2196 0.1718
33132 Blue 117 19.4 14.9 0.1855 0.1671 0.1796 0.1363
33321 Blue 117 19.0 13.3 0.1831 0.1507 0.1824 0.1383
31332 Green 112 18.7 13.1 0.1730 0.1746 0.4415 0.1888
32323 Blue 117 18.0 12.6 0.1728 0.1397 0.1718 0.1316
33223 Green 112 16.3 13.3 0.1457 0.1801 0.1548 0.1387
32333 Green 112 12.0 11.7 0.0986 0.1684 0.1091 0.1221
33333 Both 229 7.0 9.1 0.0463 0.1136 0.0508 0.0888
Dead Both 229 1.5 6.1 0.0000 0.0000 0.0107 0.0503
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and 4 were all internally valid. Further research could be
undertaken using similar studies with larger respondent
samples and smaller orthogonal valuation set designs.This study also demonstrates the performance of VAS
as a valuation method for EQ-5D studies, and adds to
the literature in support of the VAS as an elicitation in-
strument [18,19]. Over the last 5–10 years the use of
Table 3 Results of the first stage analysis for the blue and green sets
GREEN SET Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
VAS rescaled
VAS raw Individual level Aggregate level Model 4
versus
Model 6
No constant With constant No constant With constant No constant With constant
Adjusted R-Sq 0.5660 0.5988 0.5281 0.5489 0.9 0.6 −0.0499
% MAE: Green Model w/ Green Observed 5.50% 2.40% 5.08% 2.38% 5.01% 2.35% 0.03%
% Residuals >5% (i.e. 5.0 for Raw, and
0.05 for Rescaled)
55% 5% 50% 10% 50% 5% 5%
% MAE: Green Model w/ Blue Observed 6.50% 3.90% 6.30% 4.08% 6.13% 4.59% −0.51%
% MAE: Green Model w/ Green Holdouts 5.15% 4.65% 5.28% 4.84% 6.03% 5.61% −0.77%
Correlation within sample (Green Model
w/ Green Observed)
0.9778 0.9945 0.9804 0.9943 0.98 0.9940 0
Correlation out of sample (Green model
w/ Blue Observed)
0.9725 0.9871 0.9731 0.9854 0.97 0.97 0.01
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6BLUE SET
VAS rescaled
VAS raw Individual level Aggregate level Model 4
versus
Model 6No Constant With Constant No Constant With Constant No Constant With Constant
Adjusted R-Sq 0.5280 0.57 0.54 0.57 0.9 0.57 0
% MAE: Blue Model w/ Blue Observed 5.40% 2.25% 5.00% 2.25% 4.90% 2.21% 0.04%
% Residuals >5% (i.e. 5.0 for Raw, and
0.05 for Rescaled)
40% 10% 40% 10% 40% 10% 0%
% MAE: Blue Model w/ Green Observed 6.37% 3.85% 5.99% 3.81% 6.25% 3.85% −0.04%
% MAE: Blue Model w/ Blue Holdouts 4.53% 2.46% 4.22% 2.63% 5.95% 2.62% −0.01%
Correlation within sample (Blue Model
w/ Blue Observed)
0.9725 0.9944 0.9745 0.9936 0.9750 0.99 0
Correlation out of sample (Blue model
w/ Green Observed)
0.9594 0.9818 0.9631 0.9821 0.9630 0.9820 0
Figure 4 VAS values from the green model (raw VAS with constant term) compared with observed VAS values from the green set.
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Figure 5 VAS values from the green model (raw VAS with constant term) compared with observed VAS values from the blue set.
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http://www.healtheconomicsreview.com/content/4/1/29VAS has declined as a means of eliciting health state val-
uations in EQ-5D studies due partly to a preference for
other methods such as Time Trade Off (TTO) and
Discrete Choice Experiments (DCE) but also reflecting a
criticism of some aspects of VAS methods [20]. One
criticism of the VAS is that it is not ‘choice-based’. This
criticism has led many researchers away from the
method towards choice based approaches such as TTO
and DCE. By beginning the VAS valuation with a rank-
ing exercise in which respondents are given the cards
one at a time and asked to place each new card in a pos-
ition based on its level of disutility relative to the other
cards in series, this protocol brings ‘choice’ directly into
the valuation process. In a cognitive debriefing study of
this VAS protocol [21] respondents described the deci-
sion making process in the ranking and ranking-to-VAS
stages using terms that were virtually identical to theirFigure 6 Comparison of the coefficients of model 2 from the green, bdescription of their approaches in performing paired
comparisons for a DCE. These and other theoretical is-
sues concerning the VAS have been partially dealt with
[18,19,22] but there is still resistance to accepting VAS-
based valuations in economic evaluation as can be seen
in the technical guidance published by national regula-
tory agencies. Nonetheless, VAS methods are widely
used to record consumer preferences in a variety of non-
health settings whilst it continues to remain a legitimate
method for obtaining the value of self-reported health
status—notably as part of the EQ-5D instrument.
Conclusion
The studies by Lamers [6], and Zarate and Kind [7] sug-
gest that the states that are included in the valuation set
have an influence on the model that is obtained in the
analysis. In this study, 230 similar subjects (students)lue and combined data sets.
Table 4 Comparison of the 5 models based on the combined set
Baseline model N1 N2 N3 C3Sq
Constant 0.8685 0.9830 0.8865 0.9279 0.8921
MO2 −0.1350 −0.1437 −0.1084 −0.1442 −0.1395
MO3 −0.3874 −0.4061 −0.3725 −0.3749 −0.4325
SC2 −0.0975 −0.1061 −0.0766 −0.0876 −0.0911
SC3 −0.1614 −0.1802 −0.1581 −0.1394 −0.2023
UA2 −0.0764 −0.0850 −0.0613 −0.0475 −0.0674
UA3 −0.0988 −0.1176 −0.1070 −0.0673 −0.1322
PD2 −0.0495 −0.0650 −0.0289 −0.0587 −0.0523
PD3 −0.1390 −0.1510 −0.1362 −0.1265 −0.1807
AD2 −0.0410 −0.0426 −0.0202 −0.0494 −0.0420





Adj R Sq 0.5550 0.5597 0.5588 0.5647 0.5597
Correl Model vs Observed 0.9816 0.9847 0.9840 0.9881 0.9867
% MAE Model vs Observed 3.0% 3.1% 2.7% 2.4% 2.7%
% MAE Model vs Holdouts 2.8% 2.8% 3.5% 1.5% 2.6%
% Residuals >0.05 11% 13% 21% 11% 13%
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http://www.healtheconomicsreview.com/content/4/1/29divided into two groups each gave VAS valuations of two
different sets of EQ-5D states (with no common states be-
tween them). When the two data sets were analyzed using
the same regression methods, they produced strikingly
similar models that performed creditably. This is despite
the disadvantages that the orthogonal valuation sets would
present (the inclusion of implausible states, and the con-
centration of states in the moderate range). These encour-
aging results suggest that further research should be
undertaken into using orthogonal array based approaches
to developing valuation sets for EQ-5D valuation studies.
This study employed orthogonal arrays with 18 rows
(producing valuation sets of 18 states). Further research
should be undertaken to test smaller orthogonal designs
that can used to produce main effects models. This
would allow for smaller samples thus reducing the cost
of conducting valuation studies in developing countries.
Small orthogonal designs may also permit valuation sub-
sets for TTO studies that do not require blocking, such
that each respondent can provide one replicate.
This study found small differences in performance of
the models based on data transformed at the level of the
individual and at the aggregate level. Differences in per-
formance between the models based on raw VAS data
and the models based on transformed data were also
very small. The inclusion of the constant term improved
the performance of all of the models.Endnotes
aIn Table 1, One Respondent gave their self-reported
state as 31111. This is not likely, given the location at
which the interviews were conducted. This rating was
missed by the interviewer.
bIn Table 2, the data for one respondent were acciden-
tally lost.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HB and ALF conceived of the elicitation idea and oversaw the elicitation
process. HB and PK designed the props. HB and ALF conducted the analysis
for the first stage models, and PK led the analysis and modeling for the
second stage models. All three authors jointly wrote the 4 sections of the
manuscript. All authors read and approved the final manuscript.
Author details
1Arthur Lok Jack Graduate School of Business, The University of the West Indies,
St. Augustine Campus, Max Richards Drive, Uriah Butler Highway, Champs Fleurs,
Trinidad and Tobago. 2HEU, Centre for Health Economics, The University of the
West Indies, St. Augustine Campus. 25A Warner Street, St. Augustine, Trinidad and
Tobago. 3Academic Unit of Health Economics, Institute of Health Sciences,
University of Leeds, Leeds LS2 9LJ, United Kingdom.
Received: 21 July 2014 Accepted: 27 October 2014
References
1. Health Utilities Index [homepage on the internet]. Hamilton ON, Canada: HU
Inc;c1998-2014 [updated 2014 March 13; cited 2014 March 30]:
Available from: http://www.healthutilities.com/.
Bailey et al. Health Economics Review 2014, 4:29 Page 11 of 11
http://www.healtheconomicsreview.com/content/4/1/292. Brazier J, Roberts J, Deverill M: The estimation of a preference-based
measure of health from the SF-36. J Health Econ 2002, 21:271–292.
3. Group MVH: The Measurement and Valuation of Health: First report on the
main survey. 1994.
4. Dolan P, Kind P, Williams A: The time trade-off method: results from a
general population study. Health Econ 1996, 15:209–231.
5. Macran S, Kind P: Valuing EQ-5D health states using a modified MVH
protocol: preliminary results. In Proceedings of the 16th Plenary Meeting of
the EuroQol Group. Edited by Badia X, Herdman M, Roset M. Barcelona,
Spain: EuroQol Research Group 2000; 1999.
6. Lamers L, McDonnell J, Stalmeier P, Krabbe P, Bussbach J: The Dutch tariff:
results and arguments for an effective design for national EQ-5D
valuation studies. Health Econ 2006, 15:1121–1132.
7. Zarate V, Kind P: Efficient Survey Design for EQ-5D Valuation Studies: Revising
the 17 Macran-Kind Set. Rotterdam, Holland: 29th Plenary Meeting of the
EuroQol Group; 2012.
8. Chevalier J, Pourvoville G: Valuing EQ-5D using time trade-off in France.
Eur J Health Econ 2013, 14(1):57–66.
9. Scalone L, Cortesi P, Ciampichini R, Belisari A, D'Angilella L, Cesana G,
Mantovani L: Italian population-based values of EQ-5D health states.
Value Health 2013, 16:814–822.
10. Lee Y, Nam H, Chuang L, Kim K, Yang H, Kwon I, Kind P, Kweon S, Kim Y:
South Korean time trade off values for
EQ-5D health states: modeling with observed values for 101 health
states. Value Health 2009, 12:1187–1193.
11. Bagust A: Improving valuation sampling of EQ-5D health states. Health
Qual Life Outcomes 2013, 11:14.
12. Devlin N, Krabbe P: The development of new research methods for the
valuation of EQ-5D-5L. Eur J Health Econ 2013, 14:1–3.
13. Montgomery D: Design and Analysis of Experiments. 8th edition. New York:
Wiley; 2012.
14. Szende A, Oppe M, Devlin N (Eds): EQ-5D value sets: inventory, comparative
review and user guide. Dordrecht: Springer; 2007.
15. N.Sloane’s library of orthogonal arrays. http://neilsloane.com/oadir/index.html.
16. Thurstone LL: A law of comparative judgement. Psych Rev 1927, 34:273–286.
17. Oaxaca R, Dickinson D: The equivalence of panel data estimators under
orthogonal experimental design, Working paper 05–07, Appalachian State
University. 2005.
18. Parkin D, Devlin N: Is there a case for using visual analogue scale
valuations in cost utility analysis? Health Econ 2006, 15:653–664.
19. Chuang L, Kind P: Ordinal or cardinal? the VAS strikes back. Value Health
2007, 10:A454–A455.
20. Brazier J, Ratcliffe J, Tsuchiya A, Salomon J: Measuring and Valuing Health
Benefits for Economic Evaluation. New York: Oxford University Press; 2007.
21. Bailey H, Kind P, Lascelles K: What are we asking? What are they thinking?
Preliminary results from a cognitive debriefing study of EQ-5D elicitation
exercises. In Proceedings of the 28th Plenary meeting of the EuroQol Group.
Edited by Yfantopoulos J. Athens, Greece: EuroQol Group 2011; 2010.
22. Torrance G, Feeny D, Furlong W: Visual analogue scales: do they have a
role in the measurement of preferences for health states? Med Decis
Making 2001, 21:329–334.
doi:10.1186/s13561-014-0029-z
Cite this article as: Bailey et al.: Results from an exploratory study to test
the performance of EQ-5D-3L valuation subsets based on orthogonal
designs, and an investigation into some modeling and transformation
alternatives for the utility function. Health Economics Review 2014 4:29.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
